Page 75 - Read Online

Page 10 of 12 Conti et al. J Cancer Metastasis Treat 2019;5:64 I http://dx.doi.org/10.20517/2394-4722.2019.015

Copyright
© The Author(s) 2019.

REFERENCES
1. Cozzo AJ, Fuller AM, Makowski L. Contribution of adipose tissue to development of cancer. Compr Physiol 2018;8:237-82.
2. Alwarawrah Y, Kiernan K, MacIver NJ. Changes in nutritional status impact immune cell metabolism and function. Front Immunol
2018;9:1055.
3. Martinez-Useros J, Garcia-Foncillas J. Obesity and colorectal cancer: molecular features of adipose tissue. J Transl Med 2016;14:21.
4. Matafome P, Seica R. Function and dysfunction of adipose tissue. Adv Neurobiol 2017;19:3-31.
5. Longo M, Zatterale F, Naderi J, Parrillo L, Formisano P, et al. Adipose Tissue dysfunction as determinant of obesity-associated metabolic
complications. Int J Mol Sci 2019;20.
6. Guzik TJ, Skiba DS, Touyz RM, Harrison DG. The role of infiltrating immune cells in dysfunctional adipose tissue. Cardiovasc Res
2017;113:1009-23.
7. Del Corno M, Conti L, Gessani S. Innate lymphocytes in adipose tissue homeostasis and their alterations in obesity and colorectal cancer.
Front Immunol 2018;9:2556.
8. Meiliana A, Dewi NM, Wijaya A. Adipose tissue, inflammation (meta-inflammation) and obesity management. Indones Biomed J
2015;7:129-46.
9. Masoodi M, Kuda O, Rossmeisl M, Flachs P, Kopecky J. Lipid signaling in adipose tissue: connecting inflammation & metabolism.
Biochim Biophys Acta 2015;1851:503-18.
10. Saini RK, Keum YS. Omega-3 and omega-6 polyunsaturated fatty acids: dietary sources, metabolism, and significance - a review. Life Sci
2018;203:255-67.
11. Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enteral Nutr 2015;39:18S-32.
12. Ralston JC, Lyons CL, Kennedy EB, Kirwan AM, Roche HM. Fatty acids and NLRP3 inflammasome-mediated inflammation in metabolic
tissues. Annu Rev Nutr 2017;37:77-102.
13. Rocha DM, Bressan J, Hermsdorff HH. The role of dietary fatty acid intake in inflammatory gene expression: a critical review. Sao Paulo
Med J 2017;135:157-68.
14. van der Beek CM, Dejong CHC, Troost FJ, Masclee AAM, Lenaerts K. Role of short-chain fatty acids in colonic inflammation,
carcinogenesis, and mucosal protection and healing. Nutr Rev 2017;75:286-305.
15. Hodson L, Skeaff CM, Fielding BA. Fatty acid composition of adipose tissue and blood in humans and its use as a biomarker of dietary
intake. Prog Lipid Res 2008;47:348-80.
16. Vaittinen M, Mannisto V, Kakela P, Agren J, Tiainen M, et al. Interorgan cross talk between fatty acid metabolism, tissue inflammation, and
FADS2 genotype in humans with obesity. Obesity (Silver Spring) 2017;25:545-52.
17. Garaulet M, Perez-Llamas F, Perez-Ayala M, Martinez P, de Medina FS, et al. Site-specific differences in the fatty acid composition of
abdominal adipose tissue in an obese population from a Mediterranean area: relation with dietary fatty acids, plasma lipid profile, serum
insulin, and central obesity. Am J Clin Nutr 2001;74:585-91.
18. Richelsen B, Pedersen SB, Moller-Pedersen T, Bak JF. Regional differences in triglyceride breakdown in human adipose tissue: effects of
catecholamines, insulin, and prostaglandin E2. Metabolism 1991;40:990-6.
19. Raclot T, Groscolas R. Differential mobilization of white adipose tissue fatty acids according to chain length, unsaturation, and positional
isomerism. J Lipid Res 1993;34:1515-26.
20. Merino DM, Ma DW, Mutch DM. Genetic variation in lipid desaturases and its impact on the development of human disease. Lipids Health
Dis 2010;9:63.
21. Wajchenberg BL. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev 2000;21:697-738.
22. Ibrahim MM. Subcutaneous and visceral adipose tissue: structural and functional differences. Obes Rev 2010;11:11-8.
23. Mathis D. Immunological goings-on in visceral adipose tissue. Cell Metab 2013;17:851-9.
24. Esser N, Legrand-Poels S, Piette J, Scheen AJ, Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes.
Diabetes Res Clin Pract 2014;105:141-50.
25. Keane KN, Calton EK, Carlessi R, Hart PH, Newsholme P. The bioenergetics of inflammation: insights into obesity and type 2 diabetes. Eur
J Clin Nutr 2017;71:904-12.
26. D'Archivio M, Scazzocchio B, Giammarioli S, Fiani ML, Vari R, et al. omega3-PUFAs exert anti-inflammatory activity in visceral
adipocytes from colorectal cancer patients. PLoS One 2013;8:e77432.
27. Del Corno M, D'Archivio M, Conti L, Scazzocchio B, Vari R, et al. Visceral fat adipocytes from obese and colorectal cancer subjects
exhibit distinct secretory and omega6 polyunsaturated fatty acid profiles and deliver immunosuppressive signals to innate immunity cells.
Oncotarget 2016;7:63093-105.
28. Gong J, Campos H, McGarvey S, Wu Z, Goldberg et al. Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic
syndrome prevalence in Costa Rican adults. J Nutr 2011;141:2211-8.
29. Scazzocchio B, Vari R, Silenzi A, Giammarioli S, Masotti A, et al. Dietary habits affect fatty acid composition of visceral adipose tissue in
subjects with colorectal cancer or obesity. Eur J Nutr 2019; doi: 10.1007/s00394-019-02003-7.
30. May-Wilson S, Sud A, Law PJ, Palin K, Tuupanen S, et al. Pro-inflammatory fatty acid profile and colorectal cancer risk: A Mendelian
randomisation analysis. Eur J Cancer 2017;84:228-38.
31. Iggman D, Arnlov J, Cederholm T, Riserus U. Association of adipose tissue fatty acids with cardiovascular and all-cause mortality in elderly
men. JAMA Cardiol 2016;1:745-53.
32. van Dijk SJ, Feskens EJ, Bos MB, Hoelen DW, Heijligenberg R, et al. A saturated fatty acid-rich diet induces an obesity-linked